283 related articles for article (PubMed ID: 30624437)
1. Interaction of functionalized nanoparticles with serum proteins and its impact on colloidal stability and cargo leaching.
Abstiens K; Maslanka Figueroa S; Gregoritza M; Goepferich AM
Soft Matter; 2019 Jan; 15(4):709-720. PubMed ID: 30624437
[TBL] [Abstract][Full Text] [Related]
2. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
3. The effect of salts in aqueous media on the formation of the BSA corona on SiO
Givens BE; Wilson E; Fiegel J
Colloids Surf B Biointerfaces; 2019 Jul; 179():374-381. PubMed ID: 30999116
[TBL] [Abstract][Full Text] [Related]
4. Characterization of polymeric nanoparticles for intravenous delivery: Focus on stability.
Oliveira CL; Veiga F; Varela C; Roleira F; Tavares E; Silveira I; Ribeiro AJ
Colloids Surf B Biointerfaces; 2017 Feb; 150():326-333. PubMed ID: 27823851
[TBL] [Abstract][Full Text] [Related]
5. On the formation of protein corona on colloidal nanoparticles stabilized by depletant polymers.
Petry R; Saboia VM; Franqui LS; Holanda CA; Garcia TRR; de Farias MA; de Souza Filho AG; Ferreira OP; Martinez DST; Paula AJ
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110080. PubMed ID: 31546390
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes.
Fleischer CC; Payne CK
Acc Chem Res; 2014 Aug; 47(8):2651-9. PubMed ID: 25014679
[TBL] [Abstract][Full Text] [Related]
7. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
8. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
9. Enhanced colloidal stability and protein resistance of layered double hydroxide nanoparticles with phosphonic acid-terminated PEG coating for drug delivery.
Cao Z; Adnan NNM; Wang G; Rawal A; Shi B; Liu R; Liang K; Zhao L; Gooding JJ; Boyer C; Gu Z
J Colloid Interface Sci; 2018 Jul; 521():242-251. PubMed ID: 29574343
[TBL] [Abstract][Full Text] [Related]
10. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
[TBL] [Abstract][Full Text] [Related]
11. Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles.
Nguyen VH; Meghani NM; Amin HH; Tran TTD; Tran PHL; Park C; Lee BJ
Colloids Surf B Biointerfaces; 2018 Oct; 170():179-186. PubMed ID: 29906703
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
13. On the role of surface composition and curvature on biointerface formation and colloidal stability of nanoparticles in a protein-rich model system.
Orts-Gil G; Natte K; Thiermann R; Girod M; Rades S; Kalbe H; Thünemann AF; Maskos M; Österle W
Colloids Surf B Biointerfaces; 2013 Aug; 108():110-9. PubMed ID: 23528607
[TBL] [Abstract][Full Text] [Related]
14. Protein corona precoating on redox-responsive chitosan-based nano-carriers for improving the therapeutic effect of nucleic acid drugs.
Yang H; Liu T; Xu Y; Su G; Liu T; Yu Y; Xu B
Carbohydr Polym; 2021 Aug; 265():118071. PubMed ID: 33966835
[TBL] [Abstract][Full Text] [Related]
15. Albumin corona on nanoparticles - a strategic approach in drug delivery.
Mariam J; Sivakami S; Dongre PM
Drug Deliv; 2016 Oct; 23(8):2668-2676. PubMed ID: 26056719
[TBL] [Abstract][Full Text] [Related]
16. Electrokinetic Hummel-Dreyer characterization of nanoparticle-plasma protein corona: The non-specific interactions between PEG-modified persistent luminescence nanoparticles and albumin.
Ramírez-García G; d'Orlyé F; Gutiérrez-Granados S; Martínez-Alfaro M; Mignet N; Richard C; Varenne A
Colloids Surf B Biointerfaces; 2017 Nov; 159():437-444. PubMed ID: 28826112
[TBL] [Abstract][Full Text] [Related]
17. PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) Nanoparticles as Carriers for SN-38: Design, Optimization and Nano-Bio Interface Interactions.
Koliqi R; Dimchevska S; Geskovski N; Petruševski G; Chacorovska M; Pejova B; Hristov DR; Ugarkovic S; Goracinova K
Curr Drug Deliv; 2016; 13(3):339-52. PubMed ID: 26728136
[TBL] [Abstract][Full Text] [Related]
18. PEG-stabilized core-shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation.
Gillich T; Acikgöz C; Isa L; Schlüter AD; Spencer ND; Textor M
ACS Nano; 2013 Jan; 7(1):316-29. PubMed ID: 23214719
[TBL] [Abstract][Full Text] [Related]
19. Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: a route to highly peptide-functionalized biodegradable carriers.
Handké N; Ficheux D; Rollet M; Delair T; Mabrouk K; Bertin D; Gigmes D; Verrier B; Trimaille T
Colloids Surf B Biointerfaces; 2013 Mar; 103():298-303. PubMed ID: 23277324
[TBL] [Abstract][Full Text] [Related]
20. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
